Evidence map›Paper›PMID 33834160›Full record

ReviewOne health outlook2021

Assessing the risks of SARS-CoV-2 in wildlife.

R J Delahay, J de la Fuente, G C Smith, K Sharun, E L Snary, L Flores Girón, J Nziza, A R Fooks, S M Brookes, F Z X Lean and 2 more

Open access · goldAbstract readReview
In one paragraph

Review in One health outlook, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 87 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
87citing papers in PubMed, 2 pooled it
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

87 citing papers in PubMed, 2 syntheses or guidelines pooled it, 130 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Improving the ONE HEALTH approach: a lesson from SARS-CoV-2 pandemic.Journal of preventive medicine and hygiene · 2024
    Review
  13. Article
  14. Article
  15. DETECTION OF SARS-COV-2 IN A SQUIRREL MONKEY (Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians · 2024
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

27 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 6 countries.

R J DelahayNational Wildlife Management Centre, Animal and Plant Health Agency, Sand Hutton, York, YO41 1LZ UK.ORCID 0000-0001-5863-0820
J de la FuenteSaBio, Instituto de Investigación en Recursos Cinegéticos IREC-CSIC-UCLM-JCCM, Ronda de Toledo s/n, 13005 Ciudad Real, Spain.
G C SmithNational Wildlife Management Centre, Animal and Plant Health Agency, Sand Hutton, York, YO41 1LZ UK.
K SharunICAR-Indian Veterinary Research Institute, Izatnagar, Bareilly, Uttar Pradesh India.
E L SnaryDepartment of Epidemiological Sciences, Animal and Plant Health Agency, Weybridge, Woodham Lane, New Haw, Addlestone, Surrey KT15 3NB UK.
L Flores GirónCentre de Rehabilitation des Primates de Lwiro, Kinshasa, Democratic Republic of Congo.
J NzizaGorilla Doctors Inc., P.O. Box 115, Musanze, Rwanda.
A R FooksVirology Department, Animal and Plant Health Agency, Weybridge, Woodham Lane, New Haw, Addlestone, Surrey KT15 3NB UK.
S M BrookesVirology Department, Animal and Plant Health Agency, Weybridge, Woodham Lane, New Haw, Addlestone, Surrey KT15 3NB UK.
F Z X LeanPathology Department, Animal and Plant Health Agency, Weybridge, Woodham Lane, New Haw, Addlestone, Surrey KT15 3NB UK.
A C BreedSchool of Veterinary Science, University of Queensland, Brisbane, Queensland Australia.
C GortazarSaBio, Instituto de Investigación en Recursos Cinegéticos IREC-CSIC-UCLM-JCCM, Ronda de Toledo s/n, 13005 Ciudad Real, Spain.
Animal and Plant Health Agency · GBGorilla Doctors · RWIndian Veterinary Research Institute · INInstituto de Investigación en Recursos Cinegéticos · ESOklahoma State University · USQueensland University of Technology · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The novel coronavirus SARS-CoV-2 likely emerged from a wildlife source with transmission to humans followed by rapid geographic spread throughout the globe and severe impacts on both human health and the global economy. Since the onset of the pandemic, there have been many instances of human-to-animal transmission involving companion, farmed and zoo animals, and limited evidence for spread into free-living wildlife. The establishment of reservoirs of infection in wild animals would create significant challenges to infection control in humans and could pose a threat to the welfare and conservation status of wildlife. We discuss the potential for exposure, onward transmission and persistence of SARS-CoV-2 in an initial selection of wild mammals (bats, canids, felids, mustelids, great apes, rodents and cervids). Dynamic risk assessment and targeted surveillance are important tools for the early detection of infection in wildlife, and here we describe a framework for collating and synthesising emerging information to inform targeted surveillance for SARS-CoV-2 in wildlife. Surveillance efforts should be integrated with information from public and veterinary health initiatives to provide insights into the potential role of wild mammals in the epidemiology of SARS-CoV-2.

Indexed as

Covid-19Host-switchingReservoirsRisk assessmentSARS-CoV-2SurveillanceWildlife

Identifiers

PMID33834160
PMCPMC8024038
OpenAlexW3111452149

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.